Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Disease Progression × enzastaurin × CNS × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Glioblastoma 4 Glioma 3 Neoplasms 2 Brain Neoplasms 2 Gliosarcoma 1 Disease Progression 1

Interventions

vandetanib 2 Bevacizumab 2 Anthropogenic Effects 2 enzastaurin 1 carotuximab 1 Temozolomide 1 Tamoxifen 1 Steroids 1 Irinotecan 1 Carboplatin 1 Bortezomib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00108056 2019-12-05

Enzastaurin to Treat Recurrent Brain Tumor

National Institutes of Health Clinical Center (CC)

Phase 1 Terminated

Brain Neoplasms, Glioma, Neoplasms, Disease Progression

Data powered by HemOnc (CC BY 4.0) Colophon ⚡